Sep 10, 2008 by Brian Orelli, PhD1 Drug Beats Another, but Who Will Care?Not all head-to-head drug comparisons are created equal.
Sep 9, 2008 by Brian Orelli, PhDSell Dey? Perhaps Another DayThe generic-drug company decides to keep its specialty pharmaceutical subsidiary.
Sep 9, 2008 by Brian Orelli, PhDDrug Duo Combines Its Way Toward an ApprovalBristol-Myers and AstraZeneca are trying to get their diabetes drug approved as a combination treatment.
Sep 8, 2008 by Brian Orelli, PhDAnother FDA Safety Warning (Yawn)This is getting kind of ridiculous, don't you think?
Sep 5, 2008 by Brian Orelli, PhDTapping the Brakes on the Teva-Barr DealThe FTC wants more information before it offers its approval.
Sep 5, 2008 by Brian Orelli, PhDThe Right Formula in Any EconomyBabies have to eat, so Martek Biosciences is still thriving.
Sep 5, 2008 by Brian Orelli, PhDZimmer Fortifies Its SpineThe medical-device maker is buying Abbott's spine business.
Sep 3, 2008 by Brian Orelli, PhDMonsanto's Public-Relations NightmareThe agriculture giant has to defend its patents without looking like it's picking on the little guy.
Sep 2, 2008 by Brian Orelli, PhDCardiologists Hate Vytorin Merck and Schering just can't catch a break.
Sep 2, 2008 by Brian Orelli, PhDLipitor Is Back on the TubeDirect-to-consumer ads have to walk a line.
Aug 29, 2008 by Brian Orelli, PhDA Lawsuit Loss to RememberBarr and Mylan get the patent overturned on Johnson & Johnson's Alzheimer's drug.
Aug 29, 2008 by Brian Orelli, PhDMonsanto Seeds Its PipelineA continued partnership with Evogene should result in higher yields.
Aug 29, 2008 by Brian Orelli, PhDStent Makers Getting DesperateWhen competition increases, a company's got to do something.
Aug 28, 2008 by Brian Orelli, PhDGoogle Prescribes More PartnersThe online giant's health-information service snags another important ally.
Aug 28, 2008 by Brian Orelli, PhDMe-Too Drugs: Are They Worth It?These drugs have less risk, but also usually bring less of a reward.
Aug 28, 2008 by Brian Orelli, PhDStryker Strikes BackThe orthopedics maker sues to stop a costly federal investigation.
Aug 28, 2008 by Brian Orelli, PhDSchering and Pfizer Aren't Horsing AroundSchering sells some animal health products to Pfizer to keep the EU happy.
Aug 27, 2008 by Brian Orelli, PhDTeva Tells It Like It IsData from its Azilect trial looks as good as the top-line results.
